Residue-Selective Inhibitors Discovery via Covalent DNA-Encoded Chemical Libraries with Diverse Warheads
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.5c01712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Xinyuan Wu und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Hauptthemen laut MEDLINE: Small Molecule Libraries, Drug Discovery, DNA, Protein Kinase Inhibitors. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Innovative Research Team of High-level Local University in Shanghai, National Natural Science Foundation of China.
Abstract (Originalsprache)
Covalent small molecule drugs have emerged as a crucial support in precision therapy due to their high selectivity and robust potency. Covalent DNA-encoded chemical library (CoDEL) technology is an advanced platform for covalent drug discovery. However, the application of CoDELs is constrained by a single-residue focus and limited warhead diversity. Here we report a method to identify residue-selective inhibitors using CoDELs with diverse warheads targeting multiple distinct residues. We systematically evaluated the reactivity of 17 warheads with 9 nucleophilic amino acids of FGFR2 and then constructed CoDELs comprising 24.8 million compounds. These CoDELs enabled the identification of active covalent inhibitors targeting cysteine, lysine, arginine, or glutamic acid. The lysine-targeting inhibitor engaged a novel reactive site. The arginine-targeting inhibitor demonstrated subtype selectivity and overcame drug resistance. The glutamic acid-targeting inhibitor validated the druggability of this unconventional covalent residue site. These findings suggest that our work could potentially expand the target space of covalent drugs and promote precision therapy by harnessing the power of the CoDELs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China.
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, China.
- Suzhou Institute of Materia Medica, Suzhou, Jiangsu 215123, China.
- School of Pharmacy, Fudan University, Shanghai 201203, China.
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
ORCID-Profile: Mingyue Zheng, Lu Zhou, Minjia Tan, Xiaojie Lu
Förderung
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Innovative Research Team of High-level Local University in Shanghai
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- Technology and Innovation
- Shanghai Action Plan for Science
- Shanghai Talent Program
Zitieren
APA
Wu, X., Pan, J., Fan, R., Zhang, Y., Wang, C., Wang, G., Liu, J., Cui, M., Yue, J., Jin, R., Duan, Z., Zheng, M., Mei, L., Zhou, L., Tan, M., Ai, J., & Lu, X. (2025). Residue-Selective Inhibitors Discovery via Covalent DNA-Encoded Chemical Libraries with Diverse Warheads. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c01712
Vancouver
Wu X, Pan J, Fan R, Zhang Y, Wang C, Wang G, et al. Residue-Selective Inhibitors Discovery via Covalent DNA-Encoded Chemical Libraries with Diverse Warheads. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c01712
BibTeX
@article{Wu2025,
author = {Wu, Xinyuan and Pan, Jiayi and Fan, Rufeng and Zhang, Yiwei and Wang, Chao and Wang, Guoliang and Liu, Jiaxiang and Cui, Mengqing and Yue, Jinfeng and Jin, Rui and Duan, Zhiqiang and Zheng, Mingyue and Mei, Lianghe and Zhou, Lu and Tan, Minjia and Ai, Jing and Lu, Xiaojie},
title = {Residue-Selective Inhibitors Discovery via Covalent DNA-Encoded Chemical Libraries with Diverse Warheads},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.5c01712}
}
EUVIMED